TORONTO, ONTARIO--(Marketwired - April 24, 2014) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH)(CYNAF), a specialty pharmaceutical company, today announced positive data from its recently completed ...
Clinically meaningful improvement in motor control occurred in as early as 10 minutes after administration of APL-130277 and lasted longer than 90 minutes Conference call begins at 8:00 a.m. Eastern ...
TORONTO, CANADA - Cynapsus Therapeutics Inc. (CTH:TSX-V) (CYNAF:OTCQX), a specialty pharmaceutical company, today announced positive data from its recently completed CTH-104 healthy volunteer pilot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results